Kalowski Lee — SEC insider filings
SEC reporting owner CIK 1618273. 22 insider filings on record with FilingPulse; latest filed 2026-10-14.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2020-11-25 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 16 filings — 123,271 shares, $2,950,995 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 15,000 shares @ $30.00 ($450,000) in BICYCLE THERAPEUTICS plc, filed 2021-01-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BICYCLE THERAPEUTICS plc (BCYC) | President and CFO | 13 | — | 16 legs · 100,691 sh · $2,817,328 | 27 |
| Q32 Bio Inc. (QTTB) | CFO and President | 9 | — | 5 legs · 22,580 sh · $133,667 | 8 |
Insider filings — Kalowski Lee
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-14 | 4 | Q32 Bio Inc. (QTTB) | Sale (S): 1,301 @ $8.32 | EDGAR |
| 2026-08-27 | 4 | Q32 Bio Inc. (QTTB) | Sale (S): 3,972 @ $16.56 | EDGAR |
| 2026-07-20 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 53,250 @ $0 | EDGAR |
| 2026-03-20 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 53,250 @ $0 | EDGAR |
| 2026-02-27 | 4 | Q32 Bio Inc. (QTTB) | Sale (S): 3,995 @ $4.51 | EDGAR |
| 2025-12-04 | 4 | Q32 Bio Inc. (QTTB) | Sale (S): 9,072 @ $3.46 | EDGAR |
| 2025-08-28 | 4 | Q32 Bio Inc. (QTTB) | Sale (S): 4,240 @ $1.80 | EDGAR |
| 2025-02-27 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 53,250 @ $0 · Disposition to issuer (D): 16,901 (derivative) @ $0 · Grant/award (A): 16,901 (derivative) @ $0 · Disposition to issuer (D): 161,323 (derivative) @ $0 · Grant/award (A): 161,323 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 161,323 (derivative) @ $0 | EDGAR |
| 2023-04-05 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Sale (S): 376 @ $21.11 | EDGAR |
| 2023-01-05 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Grant/award (A): 17,500 @ $0 · Sale (S): 1,815 @ $29.06 · Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2021-09-03 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Option exercise (M): 10,000 @ $9.82 · Sale (S): 10,000 @ $40 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2021-08-27 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Option exercise (M): 550 @ $8.76 · Sale (S): 550 @ $35.04 · Option exercise (M): 7,950 @ $8.73 · Sale (S): 7,950 @ $35.15 · Option exercise (M): 550 (derivative) @ $0 · Option exercise (M): 7,950 (derivative) @ $0 | EDGAR |
| 2021-08-25 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Option exercise (M): 7,500 @ $1.60 · Sale (S): 7,500 @ $33.02 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2021-07-30 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Option exercise (M): 12,500 @ $1.63 · Sale (S): 8,996 @ $31.24 · Sale (S): 3,204 @ $32.13 · Sale (S): 300 @ $32.81 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2021-01-21 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Option exercise (M): 15,000 @ $1.59 · Sale (S): 15,000 @ $30 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2021-01-15 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Option exercise (M): 10,000 @ $1.60 · Sale (S): 10,000 @ $25 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Grant/award (A): 70,500 (derivative) @ $0 | EDGAR |
| 2020-12-03 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Option exercise (M): 7,500 @ $1.56 · Sale (S): 7,500 @ $22.50 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2020-11-30 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Option exercise (M): 530 @ $1.56 · Sale (S): 530 @ $20 · Option exercise (M): 530 (derivative) @ $0 | EDGAR |
| 2020-11-25 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Option exercise (M): 17,189 @ $1.56 · Sale (S): 16,976 @ $19.82 · Sale (S): 213 @ $20.38 · Option exercise (M): 9,781 @ $1.56 · Sale (S): 9,781 @ $20.07 · Option exercise (M): 17,189 (derivative) @ $0 · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1618273 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs